{"prompt": "['Carbomer and Carboxymethylcellulose', '209510', 'Clinical Protocol V1.0', 'general population who wear dentures and therefore the inclusion criteria allows for', 'investigation of typical denture users.', 'Sufficient subjects will be screened to randomize 126 to ensure 114 evaluable subjects complete', 'the entire study.', 'This study can fulfill its objectives only if appropriate subjects are enrolled. The following', 'eligibility criteria are designed to select subjects for whom participation in the study is', 'considered appropriate. All relevant medical and non-medical conditions should be taken into', 'consideration when deciding whether a subject is suitable for this protocol.', 'Subject eligibility to participate in the clinical study should be reviewed and documented by an', \"appropriate member of the investigator's study team before subjects are included in the study.\", '5.2', 'Inclusion Criteria', 'An individual must meet all of the following inclusion criteria to be eligible for enrollment into', 'the study:', '1. Subject provision of a signed and dated informed consent document indicating that the', 'subject has been informed of all pertinent aspects of the study before any assessment is', 'performed.', '2. Subject is male or female who, at the time of screening, is between the ages of 18 and 85', 'years, inclusive.', '3. A subject who is willing and able to comply with scheduled visits, treatment plan, and', 'other study procedures.', '4. A subject in good general and mental health with, in the opinion of the investigator or', 'medically qualified designee, no clinically significant/relevant abnormalities in medical', \"history or upon oral examination, or condition, that would impact the subject's safety,\", 'wellbeing or the outcome of the study, if they were to participate in the study, or affect the', \"individual's ability to understand and follow study procedures and requirements.\", '5. Female subjects of childbearing potential and at risk for pregnancy must agree to use a', 'highly effective method of contraception throughout the study and for 5 days after the last', 'dose of assigned treatment. Female subjects who are not of childbearing potential must', 'meet requirements in Section 5.5.1.', '6. Subject has denture prostheses that fulfil all of the following:', 'a.', 'A conventional acrylic full denture in either or both of the upper and lower arches.', 'The full denture may be opposed by a partial denture, natural teeth or another full', 'denture.', 'b. Dentures are well fitting (Kapur (Olshan Modification) Retention and Stability Index', 'Sum Score > 3 for each denture [maxillary and/or mandibular]) (Olshan et al, 1992)', 'with no individual stability or retention scores <1.', 'c. Denture(s) are well made (according to the well-made assessment).', '7. Subject is a habitual wearer of their denture(s) defined as subjects who wear their dentures', 'for the majority of their time whilst awake.', '8. Subject has worn their full denture(s) for at least a year.', '9. Subject has not used any denture adhesive in the last year.', '10. Subject currently adopts acceptable denture cleansing habits and routine (a minimum', 'would include daily brushing with a chemical cleaner such as toothpaste or soap, in', 'addition to at least once a week soaking in commercial denture cleansing product). Note', 'unacceptable cleaning would include cleaning with water alone or using other non-', 'specialised cleaning methods.', 'GlaxoSmithKline Consumer Healthcare Confidential', 'Template Version Effective: 18-May-18 (CCR #11475)', 'Page 18 of 65']['Carbomer and Carboxymethylcellulose', '209510', 'Clinical Protocol V1.0', '5.3', 'Exclusion Criteria', 'An individual who meets any of the following exclusion criteria will not be eligible for', 'enrollment into the study:', '1. A subject who is an employee of the investigational site, either directly involved in the', 'conduct of the study or a member of their immediate family; or an employee of the', 'investigational site otherwise supervised by the investigator; or, a GlaxoSmithKline', 'Consumer Healthcare (GSK CH) employee directly involved in the conduct of the study', 'or a member of their immediate family.', '2. A subject who has participated in other studies (including non-medicinal studies)', 'involving investigational product(s) within 30 days prior to study entry and/or during', 'study participation.', '3. A subject with, in the opinion of the investigator or medically qualified designee, an acute', 'or chronic medical or psychiatric condition or laboratory abnormality that may increase', 'the risk associated with study participation or investigational product administration or', 'may interfere with the interpretation of study results and, in the judgment of the', 'investigator or medically qualified designee, would make the subject inappropriate for', 'entry into this study.', '4. A subject who is a pregnant female.', '5. A subject who is a breastfeeding female.', '6. A subject with known or suspected intolerance or hypersensitivity to the study materials', '(or closely related compounds) or any of their stated ingredients.', '7. A subject who, in the opinion of the investigator or medically qualified designee, should', 'not participate in the study.', '8. A subject unwilling or unable to comply with the Lifestyle Considerations described in', 'this protocol.', '9. A subject who has previously been enrolled in this study.', '10. A subject who has had recent (within 30 days) gingival surgery.', '11. Taking or have taken a bisphosphonate drug (i.e. Fosamax, Actonel, Boniva).', '12. A subject with any clinically significant or relevant oral abnormality (e.g.', 'temporomandibular joint problems) that, in the opinion of the investigator, could affect the', \"subject's participation in the study.\", '13. A subject with any condition or medication which, in the opinion of the investigator, is', 'currently causing xerostomia.', '14. A subject with recent history (within the last year) of alcohol or other substance abuse.', '15. A subject with OST examination findings such as stomatitis, open sores, lesions, or swelling', 'which in the opinion of the investigator, would interfere with the conduct of the study. Mild,', 'chronic conditions commonly expected from the use of dentures in the investigators opinion,', 'are acceptable in this study.', '16. A subject who is using any medication that, in the opinion of the investigator, would', 'interfere with the conduct of the study.', '5.4', 'Randomization Criteria', 'Subjects will be randomized into the study provided they have satisfied all subject selection', 'criteria.', '5.5', 'Lifestyle Considerations', 'During the entire study (screening - completion of study):', 'GlaxoSmithKline Consumer Healthcare Confidential', 'Template Version Effective: 18-May-18 (CCR #11475)', 'Page 19 of 65']\n\n###\n\n", "completion": "END"}